Cargando…

Severe hypophosphataemia after intravenous iron administration

Iron deficiency is common and can be effectively treated with parenteral iron infusion. We report a case of an iron-deficient and vitamin D-deficient woman who developed severe symptomatic hypophosphataemia following intravenous ferric carboxymaltose administration. We stress the need of increased a...

Descripción completa

Detalles Bibliográficos
Autores principales: Anand, Gurpreet, Schmid, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353490/
https://www.ncbi.nlm.nih.gov/pubmed/28289000
http://dx.doi.org/10.1136/bcr-2016-219160
_version_ 1782515119821946880
author Anand, Gurpreet
Schmid, Christoph
author_facet Anand, Gurpreet
Schmid, Christoph
author_sort Anand, Gurpreet
collection PubMed
description Iron deficiency is common and can be effectively treated with parenteral iron infusion. We report a case of an iron-deficient and vitamin D-deficient woman who developed severe symptomatic hypophosphataemia following intravenous ferric carboxymaltose administration. We stress the need of increased awareness of this potential complication among physicians. Patients should be informed of this complication and instructed to report for follow-up if they experience new musculoskeletal symptoms or worsening of tiredness. As severe hypophosphataemia is usually symptomatic, we recommend screening symptomatic patients for this complication. Recognising and treating the possible exacerbating factors, especially vitamin D deficiency, might be a simple measure to mitigate this complication.
format Online
Article
Text
id pubmed-5353490
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-53534902017-03-21 Severe hypophosphataemia after intravenous iron administration Anand, Gurpreet Schmid, Christoph BMJ Case Rep Article Iron deficiency is common and can be effectively treated with parenteral iron infusion. We report a case of an iron-deficient and vitamin D-deficient woman who developed severe symptomatic hypophosphataemia following intravenous ferric carboxymaltose administration. We stress the need of increased awareness of this potential complication among physicians. Patients should be informed of this complication and instructed to report for follow-up if they experience new musculoskeletal symptoms or worsening of tiredness. As severe hypophosphataemia is usually symptomatic, we recommend screening symptomatic patients for this complication. Recognising and treating the possible exacerbating factors, especially vitamin D deficiency, might be a simple measure to mitigate this complication. BMJ Publishing Group 2017-03-10 /pmc/articles/PMC5353490/ /pubmed/28289000 http://dx.doi.org/10.1136/bcr-2016-219160 Text en 2017 BMJ Publishing Group Ltd This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Article
Anand, Gurpreet
Schmid, Christoph
Severe hypophosphataemia after intravenous iron administration
title Severe hypophosphataemia after intravenous iron administration
title_full Severe hypophosphataemia after intravenous iron administration
title_fullStr Severe hypophosphataemia after intravenous iron administration
title_full_unstemmed Severe hypophosphataemia after intravenous iron administration
title_short Severe hypophosphataemia after intravenous iron administration
title_sort severe hypophosphataemia after intravenous iron administration
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353490/
https://www.ncbi.nlm.nih.gov/pubmed/28289000
http://dx.doi.org/10.1136/bcr-2016-219160
work_keys_str_mv AT anandgurpreet severehypophosphataemiaafterintravenousironadministration
AT schmidchristoph severehypophosphataemiaafterintravenousironadministration